FDA
-
-
-
-
-
-
-
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
-
-
-
-
-
-
-
Talphera secures up to $29 million in private placement financing
-
-
-
-
-
-
-
Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): G
-
-
-
-
-
-
-
CorMedix inc. Announces Customer Implementation
-
-
-
-
-
-
-
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
-
-
-
-
-
-
-
CorMedix (CRMD) Added to Nasdaq Biotechnology Index
-
330,505 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

